Journals in Pharmaceutical biotechnology

Current Pharmaceutical Analysis

ISSN: 1573-4129

Current Pharmaceutical Analysis publishes full-length/mini reviews and original research articles on all the most recent advances in pharmaceutical and biomedical analysis. All aspects of the field are represented including drug analysis and pharmacological research. The journal is essential to all involved in pharmaceutical, biochemical, biomedicine and clinical analysis.This journal contains four sections:Section A (Pharmaceutical Science): This section focuses on the discovery, development, evaluation, and regulation of medications and therapies. Its main goal is to enhance human health by developing new pharmaceutical products, refining drug delivery methods, and ensuring both the safety and effectiveness of treatments.Section B (Toxicology and Pharmaceutics): This section focuses on the formulation, development, and toxicology response of drugs. It encompasses the design and testing of drug delivery systems to ensure optimal absorption, distribution, effectiveness and toxicity of medications in the body.Section C (Pharmaceutical Biotechnology): This section focuses on the utilizing biological systems, processes, or organisms to create drugs and treatments. It encompasses the development of biopharmaceuticals, including vaccines, monoclonal antibodies, gene therapies, and bionanotechnology. Additionally, it involves the application of bioengineering methods to alter cells and microorganisms for therapeutic applications.Section D (Drug Discovery): This section focuses on the identification, design, and development of new pharmaceutical compounds aimed at treating various diseases. It involves investigating novel chemical entities, natural substances, and biological molecules, utilizing methods such as high-throughput screening, molecular modeling, and structure-based drug design. The main goal is to discover safe, effective, and targeted treatments by comprehending disease mechanisms and refining lead compounds through preclinical evaluation.Editorial Board

Heliyon

ISSN: 2405-8440
5 Year impact factor: 3.9
Impact factor: 3.4

Heliyon considers research from all areas of the physical, applied, life, social and medical sciences. We publish manuscripts reporting scientifically accurate and valuable research, which adheres to accepted ethical and scientific publishing standards. As such Heliyon publishes new insights as well as extensions on existing theories, negative/null results and replication studies.Submissions covering arts, humanities and law are not considered in Heliyon. Authors of these submissions are encouraged to submit directly to our partner journal Social Sciences & Humanities Open.Heliyon classifies manuscripts/articles into different sections based on the research topic discussed. Some sections exclude certain types of studies from their scope. To know more and to see the kind of manuscripts the various sections publish, please visit: https://www.cell.com/heliyon/sectionsA dedicated in-house editorial office team, internal editors as well as external academic section and associate editors handle your manuscript and manage the publication process, giving your research the editorial support and quality control it deserves.If it's important to you, it's important to us. Submit your paper today.

Nano TransMed

ISSN: 2790-6760

Nano TransMed is an open access peer-reviewed journal that aims to provide a forum to promote and accelerate the translation of preclinical nano research to a clinical application and the communication between researchers and clinicians in a timely manner.The Journal embraces interdisciplinary and cross-boundary research and linkage between nano technology and clinical applications. Th emphasis is on hot or emerging innovative topics include preclinical applications of novel nanoscale materials, nano delivery system for stem cell-based therapy, nano fabrication and precise tissue engineering, as well as nanotechnology in pharmacology & pharmaceutics, diagnostics, targeted cancer therapy; translational outputs and evidence-based clinical outcomes of nano research. Non-nano works with significant potentials in future nanomedicine may be considered on a case by case basis.The journal contains original research papers, review articles, technical notes, editorials, and letters to the editor about matters that may benefit the wider readership of Nano TransMed.The editors welcome contributions on a variety of topics such as:Translational medicine;Nanomaterials;Nanomedicine;Nanodelivery system;Nano-fabrication;Tissue engineering;Natural product-based nanoparticles;Advanced manufacturing;Smart medical appliances and device;Stem cells;Exosomes and Extracellular Vesicles;Bioanalysis;Nanotechnology in pharmacology & pharmaceutics, diagnostics, targeted cancer therapyEditorial Board

OpenNano

ISSN: 2352-9520

OpenNano is an internationally peer-reviewed and open-access journal publishing high-quality original research articles and reviews focusing on the application of nanoscience and nanotechnology, with an emphasis on conceptual novelty and scientific quality.OpenNano publishes research from basic to translational and clinical settings with the aim to bring together pharmaceutical scientists, chemists, biotechnologists, material scientists, pharmacologists, clinicians and all others working in this exciting and challenging area.The journal publishes topics including:NanoparticlesPolymeric NanoparticlesLiposomes and Solid Lipid NanoparticlesNanovesciclesExosomesNanostructured MaterialsNanocrystals and Quantum DotsNanotubes and Nanoporous MaterialsFunctional NanomaterialsNanosystemsNanodevicesSelf-Assembly

Life Sciences

Physical Sciences & Engineering

Social Sciences & Humanities

Health

Journals in Pharmaceutical biotechnology

Current Pharmaceutical Analysis

Heliyon

Nano TransMed

OpenNano